CBS News reports two deaths tied to an unregulated weight-loss drug sold outside approved channels. The full investigation has the details.
Recap by typeshit. Full story at CBS News.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
Medscape reports national prescription data showing the pill reached that mark within two months of its January 2026 launch, with faster early uptake than injectable tirzepatide or semaglutide.
Chosun Ilbo reports Novo has raised its factory investment tenfold, to 13.4 trillion won, as demand for obesity treatments keeps climbing.
Loading…